FILING ANALYSIS · THURSDAY, OCTOBER 8
ANGIODYNAMICS INC ANGO — 8-K: Results of Operations and Financial Condition
neutral
AngioDynamics reported fiscal Q1 2027 results with net sales of $80.9 million, a 6.9% year-over-year increase, and adjusted EBITDA of $5.0 million, but the announcement lacks a significant quantified surprise to drive a substantial price move.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →